Wikidata

(Q62810985)

English

Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex

clinical trial

In more languages

Statements

title
Best Practice With Rocuronium, Neostigmine, Sugammadex, and Subjective Monitoring. (English)
0 references
start time
21 May 2018
0 references
end time
20 November 2018
0 references
number of participants
120
0 references
research intervention
rocuronium
0 references
neostigmine
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62810985&oldid=1857069179"